Esketamine is approved in Europe for treating resistant major depressive disorder

/ Depressive Disorders, Ketamine, Neuroscience, Papers, Psychology, Publications / /

Mahase, E. (2019). Esketamine is approved in Europe for treating resistant major depressive disorder.,  10.1136/bmj.l7069
Link to full text

Esketamine is approved in Europe for treating resistant major depressive disorder Read More »